Source: Annual Congress 2004 - Cardiovascular and metabolic consequences of OSA
Disease area: Respiratory critical care, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
W. Ramadan, M. Petitjean, N. Loos, S. Delanaud, G. Vardon, A. Geloen, F. Gros, G. Dewasmes (Amiens, Villeurbanne, France). Ventilatory dysregulation and sleep apnea occurence in non-obese high-fat fed rats: effect of metformin treatment. Eur Respir J 2004; 24: Suppl. 48, 2105

Member's Comments

No comment yet.

Related content which might interest you: High fat diet increases central sleep apnoeas in non obese Sprague-Dawley rats Source: Eur Respir J 2003; 22: Suppl. 45, 182s Year: 2003 Sleep apnea syndrome induced by insulin resistance in non-obese rats is reversed and prevented by metformin Source: Eur Respir J 2005; 26: Suppl. 49, 359s Year: 2005 The effects and mechanisms of chronic intermittent hypoxia on insulin resistance and glucose tolerance in non-obese rats Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016 Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial Source: Eur Respir J 2012; 39: 1398-1404 Year: 2012 Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007 The effect of 12-month growth hormone treatment on obstructive sleep apnoea in abdominally obese men Source: Annual Congress 2008 - Alternatives for continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2008 The effect of chronic intermittent hypoxia on hepatic injury and mechanism in lean mice and mice with diet-induced obesity Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014 Effects of energy restricted diet on sleep and metabolic parameters in obese Obstructive Sleep Apnea patients Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018 Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003 The effect of bariatric surgery on sleep apnea and insulin resistance in males and females with severe obesity Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Comparison of the association with sleep apnoea of obesity versus insulin resistance Source: Eur Respir J 2015; 46: 1829-1832 Year: 2015 Sleep, sleep-disordered breathing and metabolic consequences Source: Eur Respir J 2009; 34: 243-260 Year: 2009 Obstructive sleep apnoea is associated with decreased insulin sensitivity in females Source: Eur Respir J 2008; 31: 1054-1060 Year: 2008